@florianaigner "Nie, Immer, ..." diese Wörter haben in der Wissenschaft mMn keinen Platz. https://t.co/ALGA9wx2qN
Gene editing >> gene therapy Gene therapy has unfortunately had limited success with adverse effects, including patient deaths such as with high-dose AAV8 gene therapy https://t.co/Mbj58h3Qwu 4/
RT @TetsuyaIshii: High-dose AAV gene therapy deaths, via @NatureBiotech News in Brief. https://t.co/aCBbv5QMmb
High-dose AAV gene therapy deaths, via @NatureBiotech News in Brief. https://t.co/aCBbv5QMmb
@Sports_bios high AAV-doses indeed are an issue (but possibly no write-off if sufficient activity with lower dose), cf. https://t.co/oBiWF0lpnN https://t.co/q6AvRJy7Dp
RT @NatureBiotech: In Brief: The @US_FDA places @AudentesTx's phase 2 gene therapy trial for a rare neuromuscular disease on hold following…
RT @NatureBiotech: In Brief: The @US_FDA places @AudentesTx's phase 2 gene therapy trial for a rare neuromuscular disease on hold following…
RT @NatureBiotech: In Brief: The @US_FDA places @AudentesTx's phase 2 gene therapy trial for a rare neuromuscular disease on hold following…
RT @NatureBiotech: In Brief: The @US_FDA places @AudentesTx's phase 2 gene therapy trial for a rare neuromuscular disease on hold following…
RT @NatureBiotech: In Brief: The @US_FDA places @AudentesTx's phase 2 gene therapy trial for a rare neuromuscular disease on hold following…
RT @NatureBiotech: In Brief: The @US_FDA places @AudentesTx's phase 2 gene therapy trial for a rare neuromuscular disease on hold following…
In Brief: The @US_FDA places @AudentesTx's phase 2 gene therapy trial for a rare neuromuscular disease on hold following the deaths of two patients receiving the higher dose of the investigational treatment AT132 https://t.co/7LzwLUxvcG
RT @josefra1975: To take into account: High-dose AAV gene therapy deaths | Nature Biotechnology https://t.co/4INwXIEFlD
To take into account: High-dose AAV gene therapy deaths | Nature Biotechnology https://t.co/4INwXIEFlD
Still a lot to learn about AAV. High doses, liver problems and immune responses, to name a few things... https://t.co/FbUqf7oD5J
RT @JoshTycko: Sad and frustrated about more people passing away in gene therapy trials. I know it’s hard to predict outcomes, but dosing o…
RT @JoshTycko: Sad and frustrated about more people passing away in gene therapy trials. I know it’s hard to predict outcomes, but dosing o…
RT @JoshTycko: Sad and frustrated about more people passing away in gene therapy trials. I know it’s hard to predict outcomes, but dosing o…
Sad and frustrated about more people passing away in gene therapy trials. I know it’s hard to predict outcomes, but dosing over a quadrillion vector copies... That’s how you find when AAV becomes dangerous. there was already evidence in NHPs. Read: https
News in Brief|Published: 05 August 2020 https://t.co/uKuX59lIzP
High-dose AAV gene therapy deaths. https://t.co/9ukWBYZO2k https://t.co/Zw3KMVRB9G
RT @_jdevos_: High-dose AAV gene therapy results in 2 deaths: Audentes Therapeutics’ phase 2 gene therapy trial for a rare neuromuscular d…
RT @_jdevos_: High-dose AAV gene therapy results in 2 deaths: Audentes Therapeutics’ phase 2 gene therapy trial for a rare neuromuscular d…
RT @_jdevos_: High-dose AAV gene therapy results in 2 deaths: Audentes Therapeutics’ phase 2 gene therapy trial for a rare neuromuscular d…
High-dose AAV gene therapy results in 2 deaths: Audentes Therapeutics’ phase 2 gene therapy trial for a rare neuromuscular disease on hold. https://t.co/5zGfKyZGx6
RT @NatRevNeurol: Deaths linked to high-dose AAV gene therapy for myotubular myopathy https://t.co/S5Uf7Su49O
RT @NatRevNeurol: Deaths linked to high-dose AAV gene therapy for myotubular myopathy https://t.co/S5Uf7Su49O
RT @NatRevNeurol: Deaths linked to high-dose AAV gene therapy for myotubular myopathy https://t.co/S5Uf7Su49O
RT @NatRevNeurol: Deaths linked to high-dose AAV gene therapy for myotubular myopathy https://t.co/S5Uf7Su49O
RT @NatRevNeurol: Deaths linked to high-dose AAV gene therapy for myotubular myopathy https://t.co/S5Uf7Su49O
@NatureBiotech High-dose AAV gene therapy deaths https://t.co/c1k4mlCvMe
Deaths linked to high-dose AAV gene therapy for myotubular myopathy https://t.co/S5Uf7Su49O
RT @gottapatchemall: High-dose AAV gene therapy deaths https://t.co/d3OlIWrNze
RT @gottapatchemall: High-dose AAV gene therapy deaths https://t.co/d3OlIWrNze
High-dose AAV gene therapy deaths https://t.co/d3OlIWrNze